Pupillometry Guided Remifentanil Administration In Pediatric Anesthesia
NCT ID: NCT02683837
Last Updated: 2024-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2016-04-30
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pupillometry-guided Remifentanil Infusion Versus Conventional Administration in Children
NCT03749811
The Effects of Remifentanil and Remifentanil-Alfentanil Administration in Children
NCT02486926
Anesthesia for Retinopathy of Prematurity
NCT01955135
Effect of Remimazolam vs Sevoflurane Anesthesia on Incidence of Emergence Agitation and Complications in Children Undergoing Ophthalmic Surgery
NCT05527314
Optimum Dose of Remifentanil for Intubation in Small Children
NCT00474071
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard practice
Remifentanil infusion guided by usual clinical signs (heart rate, blood pressure).
Pupillometry blindly recorded. Anesthesia maintenance with sevoflurane.
Remifentanil
Sevoflurane
Administered to maintain a Bispectral Index between 40 and 60
Pupillometry
Remifentanil infusion guided by changes in pupillary diameter. Anesthesia maintenance with sevoflurane.
Remifentanil
Pupillometry
Pupillary diameter measured every 5 minutes
Sevoflurane
Administered to maintain a Bispectral Index between 40 and 60
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remifentanil
Pupillometry
Pupillary diameter measured every 5 minutes
Sevoflurane
Administered to maintain a Bispectral Index between 40 and 60
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Peripheral or central nerve block during and after surgery.
* Ophthalmological disease.
* Peroperative position with no acess to the head.
* Chronic use of medication interfering with pupillary diameter.
* Ambulatory surgery
2 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Geneva
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Walid HABRE
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Walid Habre, MD, PhD
Role: STUDY_DIRECTOR
University of Geneva
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Geneva Children's Hospital
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pupilloped
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.